Predicting and preventing the emergence of antiviral drug resistance in HSV-2

Nature Medicine

Volumn 4, Issue 6, 1998, Pages 673-678

  Blower, S M ^a,c   Porco, T C ^a   Darby, G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c AIDS Office San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG RESISTANCE; EPIDEMIC; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; MATHEMATICAL MODEL; PRIORITY JOURNAL; SEXUAL TRANSMISSION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; EPIDEMIOLOGIC STUDIES; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 2;

EID: 0031746978     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0698-673     Document Type: Article

References (36)

1. Fleming, D.T. et al. Herpes Simplex Virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337, 1105-11 (1997).
2. Nahmias, A.J., Lee, F.K. & Beckman-Nahmias, S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. 69, 19-36 (1990).
3. Oberle, M.W. et al. Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica. Amer. J. Trop. Med. Hyg 41, 224-229 (1989).
4. Marchant, J. & Roe, A. Genital herpes: recognizing and addressing patients's needs. Herpes Journal 4, 36-41 (1997).
5. Wildy, P., Field, H.J. & Nash, A.A. Classical herpes latency revisited. Soc. Gen. Microbiol. Symp. 33, 133-167 (1982).
6. Mertz, G.L., Schmidt, O. & Jourden, J.L. Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex. Transm. Dis. 12, 33-39 (1985).
7. Reichman, R.C. et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial. J. Am. Med. Assoc. 251, 2103-2107 (1984).
8. Straus, S.E. et al. Suppression offrequently recurring genital herpes: a placebo-controlled double-blind trial of oralacyclovir. N. Engl. J. Med. 310, 1545-1550 (1984).
9. Collins, P. & Darby, G. Laboratory studies of herpes simplex virus strains resistant to Acyclovir. Rev. Med. Virol. 1, 19-28 (1991)).
10. Larder, B.A. & Darby, G. Selection and characteristics of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA ploymerase activities. Virology 146, 262-271 (1985).
11. Darby, G., Field, H.J. & Salisbury, S.A. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature 289, 81-83 (1981).
12. Safrin, S. et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N. Engl. J. Med. 325, 551-555 (1991).
13. Hook, E.W. et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J. Infect. Dis. 165, 251-255 (1992).
14. Blower, S.M. & McLean, A.R. Prophylactic vaccines, risk behavior change and the probability of eradicating HIV in San Francisco. Science 265, 1451-1454 (1994).
15. Blower, S.M., Small, P.M. & Hopewell, P. Control strategies for tuberculosis epidemics: new models for old problems. Science 273, 497-500 (1996).
16. Blower, S.M. & Gerberding, J.L. The Dynamics of Drug Resistant Tuberculosis: A Theoretical Framework. J. Mol. Med. (In the press).
17. Whitely, R.J. & Gnann, J.W. Acyclovir: a decade later. New Engl. J. Med. 327, 782-789 (1992).
18. Kaplan, E.H. Economic evaluation and HIV prevention community planning - A policy analysts's perspective, in Handbook of HIV Prevention Policy Analysis (ed. Holtgrave, D.) (In the press).
19. Wald, A., Zeh, J., Barnum, G., Davis, L.G. & Corey, L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann. Intern. Med. 124, 8-15 (1996).
20. Safrin, S., Cherrington, J. & Jaffe, H.S. Clinical use of cidofovir. Rev. Med. Virol. 7, 145-156 (1997).
21. Iman, R.L. & Helton, J.C. An investigation of uncertainty and sensitivity analysis techniques for computer models. Risk Analysis 8, 71-90 (1980).
22. Mckay, M.D., Beckman, R.J. & Conover, W.J. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 21, 239-245 (1979).
23. Blower, S.M., Hartel, D., Dowlatabadi, H., May, R.M. & Anderson, R.M. Drugs, sex and HIV: a mathematical model for New York City. Phil.Trans. Roy Soc. Series B 321, 171-187 (1991).
24. Blower, S.M. & Dowlatabadi, H. Sensitivity and Uncertainty Analysis of complex models of disease transmission: an HIV model, as an example. Int. Statist. Rev. 62, 229-243 (1994).
25. Blower, S.M. et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nature Med. 1, 815-821 (1995).
26. Sanchez, M.A. & Blower, S.M. Uncertainty and sensitivity analysis of the basic reproductive rate: Tuberculosis as an example. Am. J. Epidemiol. 145, 1127-1138 (1997).
27. Porco, T.C. & Blower, S. M. Quantifying the intrinsic transmission dynamics of tuberculosis. Theor. Popul. Biol. (in the press).
28. Porco, T.C. A mathematical model of the ecology of Lyme disease. IMA J. Math. Appl. Med. Biol. (in the press).
29. Kost, R.G., Hill, E.L., Tigges, M. & Straus, S.E. Recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N. Engl. J. Med. 329, 1777-1782 (1993).
30. Englund, J.A. et al. Herpes simplex virus resistant to acyclovir. Ann. Intern. Med. 112, 416-422 (1990).
31. Wade, J.C., McLaren, C. & Meyers, J.D. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J. Infect. Dis. 148, 1077-1082 (1983).
32. Barry, D.W., Nusinoff-Lehrman, S., Ellis, M.N., Biron, K.K., & Furman, P.A. Viral resistance, clinical experience. Scand. J. Infec. Dis. Suppl. 47, 155-164 (1985).
33. Mertz, G.J., Benedetti, J., Ashley, R., Selke, S. & Corey, L. Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 116, 197-202 (1992).
34. Mertz, G.J, et al. Transmission of genital herpes in couples with one asymptomatic and one asymptomatic partner: a prospective study. J. Infect. Dis. 157, 1169-77 (1988).
35. Wald, A., Zeh, J., Selke, S., Ashley, R.L. & Corey, L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 333, 770-775 (1995).
36. Benedetti, J., Corey, L. & Ashley, R. Recurrence rates of genital herpes after acquisition of symptomatic first episode infection. Ann. Intern. Med. 121, 847-54 (1994).